The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Humanized Mice for the Study of Immuno-Oncology
Open accessAbstract
Immunotherapy is revolutionizing cancer treatment; however, complete responses are achieved in only a small fraction of patients and tumor types. Thus, there is an urgent need for predictive preclinical models to drive rational immunotherapeutic drug development, treatment combinations, and to minimize failures in clinical trials. Humanized mouse models (HIS) have been developed to study and modulate the interactions between immune components and tumors of human origin. In this review, we discuss recent advances in the 'humanization' of mouse models to improve the quality of human immune cell reconstitution. We also highlight new insights into the basic mechanisms, and provide a preclinical evaluation of onco-immunotherapies, as well as the limitations thereof, which constitute drivers for the improvement of the models to increase their translational power.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elements of cancer immunity and the cancer–immune set point
Chen, D. S., & Mellman, I. (2017) · Nature · doi:10.1038/nature21349 · Cited by 5,352
A severe combined immunodeficiency mutation in the mouse
Bosma, G. C., Custer, R. P., & Bosma, M. J. (1983) · Nature · doi:10.1038/301527a0 · Cited by 2,207
Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S. D., King, M., Mangada, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6477 · Cited by 1,728
One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23
Fogh, J., Fogh, J. M., & Orfeo, T. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/59.1.221 · Cited by 1,599
NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0207 · Cited by 1,476
RAG-1 and RAG-2, Adjacent Genes That Synergistically Activate V(D)J Recombination
Oettinger, M. A., Schatz, D. G., Gorka, C., & Baltimore, D. (1990) · Science · doi:10.1126/science.2360047 · Cited by 1,456
McCune, J., Namikawa, R., Kaneshima, H., Shultz, L., Lieberman, M., & Weissman, I. (1988) · Science · doi:10.1126/science.241.4873.1632 · Cited by 1,406
Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature Reviews Immunology · doi:10.1038/nri2017 · Cited by 1,279
Transfer of a functional human immune system to mice with severe combined immunodeficiency
Mosier, D. E., Gulizia, R. J., Baird, S. M., & Wilson, D. B. (1988) · Nature · doi:10.1038/335256a0 · Cited by 1,255
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
Cherkassky, L., Morello, A., Villena-Vargas, J., Feng, Y., Dimitrov, D. S., Jones, D. R., Sadelain, M., & Adusumilli, P. S. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83092 · Cited by 1,074
Humanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice
Traggiai, E., Chicha, L., Mazzucchelli, L., Bronz, L., Piffaretti, J.-C., Lanzavecchia, A., & Manz, M. G. (2004) · Science · doi:10.1126/science.1093933 · Cited by 993
Development and function of human innate immune cells in a humanized mouse model
Rongvaux, A., Willinger, T., Martinek, J., Strowig, T., Gearty, S. V., Teichmann, L. L., Saito, Y., Marches, F., Halene, S., Palucka, A. K., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2858 · Cited by 789
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Huntington, N. D., Legrand, N., Alves, N. L., Jaron, B., Weijer, K., Plet, A., Corcuff, E., Mortier, E., Jacques, Y., Spits, H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082013 · Cited by 577
Cytokine Stimulation of Multilineage Hematopoiesis from Immature Human Cells Engrafted in SCID Mice
Lapidot, T., Pflumio, F., Doedens, M., Murdoch, B., Williams, D. E., & Dick, J. E. (1992) · Science · doi:10.1126/science.1372131 · Cited by 535
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells
Takenaka, K., Prasolava, T. K., Wang, J. C. Y., Mortin-Toth, S. M., Khalouei, S., Gan, O. I., Dick, J. E., & Danska, J. S. (2007) · Nature Immunology · doi:10.1038/ni1527 · Cited by 509
Gill, S., Tasian, S. K., Ruella, M., Shestova, O., Li, Y., Porter, D. L., Carroll, M., Danet-Desnoyers, G., Scholler, J., Grupp, S. A., et al. (2014) · Blood · doi:10.1182/blood-2013-09-529537 · Cited by 489
Lan, P., Tonomura, N., Shimizu, A., Wang, S., & Yang, Y.-G. (2006) · Blood · doi:10.1182/blood-2005-11-4388 · Cited by 478
Zhao, Y., Moon, E., Carpenito, C., Paulos, C. M., Liu, X., Brennan, A. L., Chew, A., Carroll, R. G., Scholler, J., Levine, B. L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2880 · Cited by 450
Efficient Transplantation via Antibody-Based Clearance of Hematopoietic Stem Cell Niches
Czechowicz, A., Kraft, D., Weissman, I. L., & Bhattacharya, D. (2007) · Science · doi:10.1126/science.1149726 · Cited by 432
Vallera, D. A., Felices, M., McElmurry, R., McCullar, V., Zhou, X., Schmohl, J. U., Zhang, B., Lenvik, A. J., Panoskaltsis-Mortari, A., Verneris, M. R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2710 · Cited by 391
King, M. A., Covassin, L., Brehm, M. A., Racki, W., Pearson, T., Leif, J., Laning, J., Fodor, W., Foreman, O., Burzenski, L., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03933.x · Cited by 386
Shultz, L. D., Saito, Y., Najima, Y., Tanaka, S., Ochi, T., Tomizawa, M., Doi, T., Sone, A., Suzuki, N., Fujiwara, H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000475107 · Cited by 366
CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo
Song, D.-G., Ye, Q., Poussin, M., Harms, G. M., Figini, M., & Powell, D. J. (2012) · Blood · doi:10.1182/blood-2011-03-344275 · Cited by 355
ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
Guedan, S., Chen, X., Madar, A., Carpenito, C., McGettigan, S. E., Frigault, M. J., Lee, J., Posey, A. D., Scholler, J., Scholler, N., et al. (2014) · Blood · doi:10.1182/blood-2013-10-535245 · Cited by 353
Izumchenko, E., Paz, K., Ciznadija, D., Sloma, I., Katz, A., Vasquez-Dunddel, D., Ben-Zvi, I., Stebbing, J., McGuire, W., Harris, W., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx416 · Cited by 332
Billerbeck, E., Barry, W. T., Mu, K., Dorner, M., Rice, C. M., & Ploss, A. (2011) · Blood · doi:10.1182/blood-2010-08-301507 · Cited by 304
Pizzitola, I., Anjos-Afonso, F., Rouault-Pierre, K., Lassailly, F., Tettamanti, S., Spinelli, O., Biondi, A., Biagi, E., & Bonnet, D. (2014) · Leukemia · doi:10.1038/leu.2014.62 · Cited by 287
Chen, Q., Khoury, M., & Chen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912274106 · Cited by 271
McIntosh, B. E., Brown, M. E., Duffin, B. M., Maufort, J. P., Vereide, D. T., Slukvin, I. I., & Thomson, J. A. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.12.005 · Cited by 255
Diaconu, I., Ballard, B., Zhang, M., Chen, Y., West, J., Dotti, G., & Savoldo, B. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.01.011 · Cited by 250
Holyoake, T. L., Nicolini, F. E., & Eaves, C. J. (1999) · Experimental Hematology · doi:10.1016/s0301-472x(99)00078-8 · Cited by 248
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Ames, E., Canter, R. J., Grossenbacher, S. K., Mac, S., Chen, M., Smith, R. C., Hagino, T., Perez-Cunningham, J., Sckisel, G. D., Urayama, S., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500447 · Cited by 235
Strowig, T., Rongvaux, A., Rathinam, C., Takizawa, H., Borsotti, C., Philbrick, W., Eynon, E. E., Manz, M. G., & Flavell, R. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109769108 · Cited by 228
Brown, C. E., Starr, R., Aguilar, B., Shami, A. F., Martinez, C., D'Apuzzo, M., Barish, M. E., Forman, S. J., & Jensen, M. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1669 · Cited by 225
Willinger, T., Rongvaux, A., Takizawa, H., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Auerbach, W., Eynon, E. E., Stevens, S., Manz, M. G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019682108 · Cited by 224
Watanabe, Y., Takahashi, T., Okajima, A., Shiokawa, M., Ishii, N., Katano, I., Ito, R., Ito, M., Minegishi, M., Minegishi, N., et al. (2009) · International Immunology · doi:10.1093/intimm/dxp050 · Cited by 222
Pearson, T., Shultz, L. D., Miller, D., King, M., Laning, J., Fodor, W., Cuthbert, A., Burzenski, L., Gott, B., Lyons, B., et al. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03753.x · Cited by 220
Sanmamed, M. F., Chester, C., Melero, I., & Kohrt, H. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw041 · Cited by 207
Danner, R., Chaudhari, S. N., Rosenberger, J., Surls, J., Richie, T. L., Brumeanu, T.-D., & Casares, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019826 · Cited by 206
Legrand, N., Huntington, N. D., Nagasawa, M., Bakker, A. Q., Schotte, R., Strick-Marchand, H., de Geus, S. J., Pouw, S. M., Böhne, M., Voordouw, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101398108 · Cited by 206
Abate-Daga, D., Lagisetty, K. H., Tran, E., Zheng, Z., Gattinoni, L., Yu, Z., Burns, W. R., Miermont, A. M., Teper, Y., Rudloff, U., et al. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.209 · Cited by 191
Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy
Pallasch, C. P., Leskov, I., Braun, C. J., Vorholt, D., Drake, A., Soto-Feliciano, Y. M., Bent, E. H., Schwamb, J., Iliopoulou, B., Kutsch, N., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.041 · Cited by 179
Herndler-Brandstetter, D., Shan, L., Yao, Y., Stecher, C., Plajer, V., Lietzenmayer, M., Strowig, T., de Zoete, M. R., Palm, N. W., Chen, J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705301114 · Cited by 179
Sanmamed, M. F., Rodriguez, I., Schalper, K. A., Oñate, C., Azpilikueta, A., Rodriguez-Ruiz, M. E., Morales-Kastresana, A., Labiano, S., Pérez-Gracia, J. L., Martín-Algarra, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3510 · Cited by 170
Smith, E. J., Olson, K., Haber, L. J., Varghese, B., Duramad, P., Tustian, A. D., Oyejide, A., Kirshner, J. R., Canova, L., Menon, J., et al. (2015) · Scientific Reports · doi:10.1038/srep17943 · Cited by 167
Fisher, T. S., Kamperschroer, C., Oliphant, T., Love, V. A., Lira, P. D., Doyonnas, R., Bergqvist, S., Baxi, S. M., Rohner, A., Shen, A. C., et al. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1237-1 · Cited by 166
Establishment of a Human Allergy Model Using Human IL-3/GM-CSF–Transgenic NOG Mice
Ito, R., Takahashi, T., Katano, I., Kawai, K., Kamisako, T., Ogura, T., Ida-Tanaka, M., Suemizu, H., Nunomura, S., Ra, C., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203543 · Cited by 165
Jespersen, H., Lindberg, M. F., Donia, M., Söderberg, E. M. V., Andersen, R., Keller, U., Ny, L., Svane, I. M., Nilsson, L. M., & Nilsson, J. A. (2017) · Nature Communications · doi:10.1038/s41467-017-00786-z · Cited by 160
Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors
Münch, R. C., Muth, A., Muik, A., Friedel, T., Schmatz, J., Dreier, B., Trkola, A., Plückthun, A., Büning, H., & Buchholz, C. J. (2015) · Nature Communications · doi:10.1038/ncomms7246 · Cited by 140
Ito, A., Ishida, T., Yano, H., Inagaki, A., Suzuki, S., Sato, F., Takino, H., Mori, F., Ri, M., Kusumoto, S., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0632-0 · Cited by 133
A Model for Personalized in Vivo Analysis of Human Immune Responsiveness
Kalscheuer, H., Danzl, N. M., Onoe, T., Faust, T., WINCHESTER, R. J., Goland, R., Greenberg, E. M., Spitzer, T. R., Savage, D. G., Tahara, H., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003481 · Cited by 130
Mahne, A. E., Mauze, S., Joyce-Shaikh, B., Xia, J., Bowman, E. P., Beebe, A. M., Cua, D. J., & JAIN, R. K. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0797 · Cited by 127
Bacac, M., Klein, C., & Umaña, P. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1203498 · Cited by 119
Lute, K. D., May, K. F., Lu, P., Zhang, H., Kocak, E., Mosinger, B., Wolford, C. C., Phillips, G. S., Caligiuri, M. A., Zheng, P., et al. (2005) · Blood · doi:10.1182/blood-2005-06-2298 · Cited by 118
Improved Human Erythropoiesis and Platelet Formation in Humanized NSGW41 Mice
Rahmig, S., Kronstein‐Wiedemann, R., Fohgrub, J., Kronstein, N., Nevmerzhitskaya, A., Bornhäuser, M., Gassmann, M., Platz, A., Ordemann, R., Tonn, T., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.005 · Cited by 118
Suzuki, M., Takahashi, T., Katano, I., Ito, R., Ito, M., Harigae, H., Ishii, N., & Sugamura, K. (2012) · International Immunology · doi:10.1093/intimm/dxs045 · Cited by 115
Burova, E., Hermann, A., Waite, J. C., Potocky, T. B., Lai, V. K.-M., Hong, S., Liu, M., Allbritton, O., Woodruff, A., Wu, Q., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0665 · Cited by 115
Ma, S.-D., Xu, X., Jones, R., Delecluse, H., Zumwalde, N. A., Sharma, A., Gumperz, J. E., & Kenney, S. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005642 · Cited by 112
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
McCormack, E., Adams, K. J., Hassan, N. J., Kotian, A., Lissin, N. M., Sami, M., Mujić, M., Osdal, T., Gjertsen, B. T., Baker, D., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1384-4 · Cited by 107
Ashizawa, T., Iizuka, A., Nonomura, C., Kondou, R., Maeda, C., Miyata, H., Sugino, T., Mitsuya, K., Hayashi, N., Nakasu, Y., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0122 · Cited by 107
Hudson, W., Li, Q., Le, C., & Kersey, J. (1998) · Leukemia · doi:10.1038/sj.leu.2401236 · Cited by 103
Cany, J., van der Waart, A. B., Tordoir, M., Franssen, G. M., Hangalapura, B. N., de Vries, I. J. M., Boerman, O. C., Schaap, N. P., van der Voort, R., Spanholtz, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064384 · Cited by 94
Andre, M. C., Erbacher, A., Gille, C., Schmauke, V., Goecke, B., Hohberger, A., Mang, P., Kübler, A., Mueller, I., Herr, W., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000583 · Cited by 87
Humanized Mouse Models for the Preclinical Assessment of Cancer Immunotherapy
Wege, A. K. (2018) · BioDrugs · doi:10.1007/s40259-018-0275-4 · Cited by 85
A novel Flt3‐deficient HIS mouse model with selective enhancement of human DC development
Li, Y., Mention, J., Court, N., Masse‐Ranson, G., Toubert, A., Spits, H., Legrand, N., Corcuff, E., Strick‐Marchand, H., & Santo, J. P. D. (2016) · European Journal of Immunology · doi:10.1002/eji.201546132 · Cited by 84
Yaguchi, T., Kobayashi, A., Inozume, T., Morii, K., Nagumo, H., Nishio, H., Iwata, T., Ka, Y., Katano, I., Ito, R., et al. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.106 · Cited by 84
Lee, S. J., Kang, W. Y., Yoon, Y., Jin, J. Y., Song, H. J., Her, J. H., Kang, S. M., Hwang, Y. K., Kang, K. J., Joo, K. M., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-2034-y · Cited by 82
Hombach, A. A., Görgens, A., Chmielewski, M. M., Murke, F., Kimpel, J., Giebel, B., & Abken, H. (2016) · Molecular Therapy · doi:10.1038/mt.2016.82 · Cited by 82
Katano, I., Takahashi, T., Ito, R., Kamisako, T., Mizusawa, T., Ka, Y., Ogura, T., Suemizu, H., Kawakami, Y., & Ito, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401323 · Cited by 78
Katano, I., Nishime, C., Ito, R., Kamisako, T., Mizusawa, T., Ka, Y., Ogura, T., Suemizu, H., Kawakami, Y., Ito, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17442-7 · Cited by 77
Brehm, M., Bortell, R., Diiorio, P., Leif, J., Laning, J., Cuthbert, A., Yang, C.-X., Herlihy, M., Burzenski, L., Gott, B., et al. (2010) · Diabetes · doi:10.2337/db10-0323 · Cited by 74
Geller, M. A., Knorr, D. A., Hermanson, D., Pribyl, L. J., Bendzick, L. E., McCullar, V., Miller, J. S., & Kaufman, D. S. (2013) · Cytotherapy · doi:10.1016/j.jcyt.2013.05.022 · Cited by 73
Chang, D.-K., Moniz, R. J., Xu, Z., Sun, J., Signoretti, S., Zhu, Q. K., & Marasco, W. A. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0384-3 · Cited by 72
Naserian, S., Leclerc, M., Thiolat, A., Pilon, C., Bret, C. L., Belkacémi, Y., Maury, S., Charlotte, F., & Cohen, J. L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00010 · Cited by 71
Evert, J. S. H., Cany, J., van den Brand, D., Oudenampsen, M., Brock, R. E., Torensma, R., Bekkers, R. L. M., Jansen, J. H., Massuger, L. F. A. G., & Dolstra, H. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1320630 · Cited by 70
Humanized Mice as a Model for Aberrant Responses in Human T Cell Immunotherapy
Vudattu, N. K., Waldron-Lynch, F., Truman, L. A., Deng, S., Preston‐Hurlburt, P., Torres, R., Raycroft, M. T., Mamula, M. J., & Herold, K. C. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302455 · Cited by 67
Stadler, C., Bähr-Mahmud, H., Plum, L. M., Schmoldt, K., Kölsch, A. C., Türeci, Ö., & Şahin, U. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1091555 · Cited by 66
Humanized NOD/LtSz‐scid IL2 Receptor Common Gamma Chain Knockout Mice in Diabetes Research
Shultz, L. D., Pearson, T., King, M., Giassi, L. J., Carney, L., Gott, B., Lyons, B. L., Rossini, A. A., & Greiner, D. L. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1394.002 · Cited by 63
Conserved and divergent aspects of human T‐cell development and migration in humanized mice
Halkias, J., Yen, B., Taylor, K. T., Reinhartz, O., Winoto, A., Robey, E. A., & Melichar, H. J. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.38 · Cited by 61
A functional DC cross talk promotes human ILC homeostasis in humanized mice
Lopez‐Lastra, S., Masse‐Ranson, G., Fiquet, O., Darche, S., Serafini, N., Li, Y., Dusséaux, M., Strick‐Marchand, H., & Santo, J. P. D. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017004358 · Cited by 58
Veluchamy, J. P., Lopez-Lastra, S., Spanholtz, J., Bohme, F., Kok, N., Heideman, D. A. M., Verheul, H. M. W., Di Santo, J. P., de Gruijl, T. D., & van der Vliet, H. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00087 · Cited by 54
Gille, C., Orlikowsky, T. W., Spring, B., Hartwig, U. F., Kübler, A., Wirth, A., Goecke, B., Handgretinger, R., Poets, C. F., & Andre, M. C. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.01.006 · Cited by 53
Levin, A. G., Waks, T., & Eshhar, Z. (2014) · Molecular Therapy · doi:10.1038/mt.2014.28 · Cited by 49
Leskov, I. B., Pallasch, C. P., Drake, A. C. B., Iliopoulou, B. P., de Souza, A. P. D., Shen, C.-H., Schweighofer, C. D., Abruzzo, L. V., Frenzel, L. P., Wendtner, C. ‐., et al. (2012) · Oncogene · doi:10.1038/onc.2012.117 · Cited by 49
Pérol, L., Martin, G. H., Maury, S., Cohen, J. L., & Piaggio, E. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.10.027 · Cited by 43
Self-citationRossi, M. I. D., Medina, K. L., Garrett, K. P., Kolar, G. R., Comp, P. C., Shultz, L. D., Capra, J. D., Wilson, P. C., Schipul, A. H., & Kincade, P. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3033 · Cited by 40
Calvo, E., Soria, J., Ma, W. W., Wang, T., Bahleda, R., Tolcher, A. W., Gernhardt, D., O'Connell, J. P., Millham, R., Giri, N., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2301 · Cited by 40
Zeng, Y. C., Liu, B., Rubio, M., Wang, X., Ojcius, D. M., Tang, R., Dürrbach, A., Ru, Z., Zhou, Y., & Lone, Y. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173754 · Cited by 40
Wege, A. K., Weber, F., Kroemer, A., Ortmann, O., Nimmerjahn, F., & Brockhoff, G. (2016) · Oncotarget · doi:10.18632/oncotarget.13159 · Cited by 32
Modeling Human Leukemia Immunotherapy in Humanized Mice
Xia, J., Hu, Z., Yoshihara, S., Li, Y., Jin, C.-H., Tan, S., Li, W., Chen, Q., Sykes, M., & Yang, Y. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.028 · Cited by 27
Wulf-Goldenberg, A., Eckert, K., & Fichtner, I. (2010) · Cytotherapy · doi:10.3109/14653249.2010.515577 · Cited by 17
Cited by
Ganesh, K., & Massagué, J. (2021) · Nature Medicine · doi:10.1038/s41591-020-01195-4 · Cited by 1,051
Therapeutic cancer vaccines: Advancements, challenges, and prospects
Fan, T., Zhang, M., Yang, J., Zhu, Z., Cao, W., & Dong, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01674-3 · Cited by 597
Turning cold tumors hot: from molecular mechanisms to clinical applications
Zhang, J., Huang, D., Saw, P. E., & Song, E. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.04.010 · Cited by 534
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Boire, A., Brastianos, P. K., Garzia, L., & Valiente, M. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0220-y · Cited by 446
Metadata
- Authors
- De La Rochere, P., Guil-Luna, S., Decaudin, D., Azar, G., Sidhu, S. S., & Piaggio, E.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 39
- Issue
- 9
- Pages
- 748-763
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W2887928126
- Cited by
- 291
- References
- 93
- FWCI
- 3.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.